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Abstract
Human Papilloma Virus (HPV) is a widespread sexually transmitted disease
which can lead to cervical cancer. Understanding the factors influencing HPV
transmission has been a challenge for scientists and policy makers. We have
found that previous modeling studies have not sufficiently accounted for the
structural and temporal features of the sexual networks underlying HPV trans-
mission. The aim of this study is to investigate HPV transmission processes and
vaccination strategies with a dynamic relationship-based transmission mod-
el. We calibrate the epidemic model with real-world network data, and study
the transmission processes with different network parameters and transmission
rates. We show that a pure vaccination strategy (vaccinating only one gender)
is most efficient if female-to-male and male-to-female transmission rates are e-
qual. However, there has been recent evidence in the literature indicating that
female-to-male transmission rate might be higher. Incorporating these findings
into our model lead to the conclusion that male vaccination is more effective.
Finally, based on our simulation results, we provide some suggestions for opti-
mal HPV vaccination strategies.
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1 Introduction
Cervical cancer is the second most common cancer for women worldwide, with
about 500 000 new cases and 250 000 deaths each year [22]. The relationship of
cervical cancer and sexual activity was suspected for more than 100 years, and it
was not until the 1960s that studies showing a consistent association between hu-
man papilloma virus (HPV) and cervical cancer were published [12]. Later, people
have detected HPV in 99% of cervical cancers by Polymerase Chain Reaction (PCR)
methodology [12], and now it is generally accepted that HPV is necessary for the
development of cervical cancer [24].
Furthermore, studying cases from all over the world, HPV is also known to be
associated with other types of cancers, including nearly 40% of penile cancers, 40%
of vulvar and vaginal cancers, and 40% of anal cancers [24]. It has been suggested
that around 26% of head and neck cancers are attributable to HPV, but prevalence
varies depending on the tumor location [6].
There are more than 100 types of HPV, and about 40 types can cause genital dis-
eases. We can also divide the 40 types of HPVs into two categories:
• Low-risk HPVs, which do not cause cancer but can cause skin warts on or
around the genitals or anus and will eventually resolve over weeks or months
• High-risk or oncogenic HPVs, which can persist and cause cancer for some in-
fected individuals. At least a dozen high-risk HPV types have been identified.
HPV types 16 and 18, are responsible for 70% of HPV-caused cancers [12].
Besides its association with various types of cancers and genital diseases, we are
interested in studying HPV transmission because of its subclinical and asymptomat-
ic presentation [23]. Due to the lack of symptom, most infected individuals do not
know they have HPV. Therefore, this virus can be spread easily and unconscious-
ly during sexual encounters [23]. Studies have shown that at least 50% of men and
women will acquire genital HPV infection during their lifetime [23], and HPV is cur-
rently the most common sexually transmitted disease (STD) in the United States
[12]. Due to HPV’s direct association with various genital diseases and cancers and
its high prevalence, HPV poses a major public health concern. HPV vaccinations
were first licensed in 2006 [12], and the vaccination rates vary dramatically by s-
tates: According to the C.D.C’s (Centers for Disease Control and Prevention) data for
2011 [11], Rhode Island had the highest vaccination rate, with 57 percent of adoles-
cent girls fully inoculated, followed by Vermont and South Dakota, both 50 percent.
Arkansas had the lowest, 15 percent, less than half the national rate. Other states
with low rates were Mississippi and Utah, at 20 percent, and Kansas, at 22 percent.
Moreover, controversy about the most efficient vaccination strategy still remains. Al-
though most research addresses the vaccination impact on female health outcomes,
it has long been questioned whether optimizing HPV vaccine efficacy also requires
immunizing males. In order to find the best vaccination strategy, we need to un-
derstand how HPV transmits. The subclinical and asymptomatic presentation of H-
PV makes its transmission process unobvious, and epidemiological research is both
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time-consuming and expensive. Thus, mathematical modeling becomes an attrac-
tive tool for HPV transmission studies.
Many past studies have discussed various epidemiological models in homoge-
neously mixing populations. For example, Neyman [21] explained the determinis-
tic mean-field and stochastic models for recurrent epidemics; Adler and Brunet [1]
described an ODE model in which individuals can be infected simultaneously by
co-circulating diseases; Castillo-Chavez et al [9] set up discrete and continuous time
models with age structures. Furthermore, many researchers [7, 3, 18] investigated
mathematical models for HPV transmission in homogeneously mixing population-
s. While homogeneously mixing population models are suitable for the spread of
diseases that are transmitted through air or water, such as flu, they might not be
suitable for STDs, such as HPV. According to Bearman [4], sexual network structures
and partner-selection processes play an important role in HPV transmission. Past
studies [20, 27] have modeled diffusion through static networks, but the time order-
ing of relationships in a sexual network affects STD transmission as well [19, 14]. For
example, consider the 3-node network illustrated in Figure 1.
Figure 1: Static sexual network structure between A,B and C. B is in relationship with
A and C, but A and C are not in a relationship.
Three people A,B and C form a static network structure as Figure 1. Assume that
B is in relationship with both A and C, and A has a certain kind of STD. On the static
network graph, we don’t know about the timing of relationships, and both A and B,
B and C have formed a sexual relationship, so A can infect C via infecting B. In the
static case, C will have a chance to be infected. Next, consider that case of time-
ordered relationships. If A has a sexual relationship with B before B contacts with
C, B will possibly transmit the disease to C after being infected by A. On the other
hand, if A has a sexual relationship with B after B contacts with C, then C cannot
be infected with the disease. From this simple example, we see results of epidemic
transmission with dynamic network models differ from results with static network
models.
The goal of our study is to investigate HPV transmission with a dynamic random
graph approach and explore optimal HPV vaccination strategies. We have found that
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as most infected people became resistant, the total sum of infected people would
decrease in the long run and most of the remaining infected population were per-
sistently infected with the high-risk HPVs and had a high probability of developing
cancer. From past studies, we have found various statements about HPV transmis-
sion rates, so we studied HPV vaccination strategy under different transmission dy-
namics. We verified that it was most efficient to vaccinate only females when trans-
mission rates were the same across genders. But we also found that vaccinating
males could be beneficial under the assumption that female-to-male transmission
rates were higher.
2 Model Set-up
In order to study HPVs in a dynamic random network, we first referred to Moody’s
work [19] and developed a dynamic model for heterosexual partnership formation,
parameterized through a 18-month study conducted by Bearman et al [4] in Jeffer-
son High School. We chose Jefferson High School as our network model because
the highest risk of HPV infection happens during adolescents between 15-19 years
old [23], which is just the time for high school. This study was carried out among
429 female and 403 male teenagers and formed 474 relationships cumulatively in
18 months. Then we added the disease model to the network model by making as-
sumptions about the initial infected population and other HPV epidemic parame-
ters.
2.1 Bipartite Markov Chain NetworkModel
HPVs only transmit via sexual contact. In order to understand HPVs’ transmission
processes, we build a bipartite Markov Chain network model, and we make the fol-
lowing assumptions:
• There are N heterosexual individuals in the total population, which can be
divided into Nm number of men and N f of women, i.e. Nm +N f =N .
• For the sake of simplicity, we only count heterosexual relationships in the net-
work.
• In the beginning, everyone in the population is single.
• In the continuous time Markov process model, we assume formation of rela-
tionships are random and independent, which means that one arbitrary node
can connect with any random node regardless of how many relationships the
nodes are involved in at the time.
• Any two random nodes form a relationship at the rate of β.
• Random relationships break up at the rate of γ.
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Figure 2: S-(I,PI)-R Figure 3: S-I-(R,PI)
2.2 Relationship-based Dynamic HPV TransmissionModel
In the population, we denote the state of susceptible as S, infected (excluding per-
sistently infected) as I, persistently infected as PI, and resistent as R. And we define
rsi as the rate of transmission in an S-I or S-PI relationship, ri as the rate of recov-
ery, and θ as the probability of being persistently infected for one individual. We use
continuous time Markov process to model HPV transmission, and Figure 2 and 3 de-
scribe two possible transmission dynamics. In Figure 2, we assume HPV persistence
is an intrinsic property, which means that whether an individual is I or PI depend-
s only on his or her immune capacity. Thus, after a susceptible individual is being
infected at the rate rsi , we know immediately that the person has probability θ of be-
ing persistently infected, and with probability (1−θ) the person is I and will recover
and gain resistance at the rate of ri . We name this S-(I,PI)-R model. In Figure 3, we
assume the outcome of infection is a race against time. After a susceptible individu-
al is infected, he becomes either persistently infected with rate θri , or resistent with
rate (1−θ)ri , depending on which event happens first. We name it S-I-(R,PI) model.
In reality, neither infected people or persistently infected people have symptoms, so
we don’t know whether HPV persistence is an intrinsic property or a race between
two events. Thus, both models are possible biologically. However, for the interest of
our study, which is to explore the vaccination strategy to decrease both I+PI and PI,
S-(I,PI)-R and S-I-(R,PI) models will give us the same result of I+PI at any time of t
(the reader can refer to Appendix for detailed proof). Moreover, we know that in the
long run, θ · (I+PI) in the S-(I,PI)-R model equals to PI in S-I-(R,PI). In the S-I-(R,PI)
model, the number of PI may still increase after the time we stopped simulation be-
cause I will continue change to PI. Our primary goal is to find a vaccination strategy
that minimizes the number of PI in the long run. Therefore, for us, the S-(I,PI)-R
model is a better choice of our HPV epidemiological study, because it will give us
the final count of PI.
3 Parameter Estimation
3.1 Relationship Formation Rate perWeek (β)
In Bearman’s study [4], there are 474 relationships formed cumulatively in 18 month-
s between 429 females and 403 males. We denote N f as the number of females
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in the population, which is 429 in this case, and Nm as the number of males in
the population, which is 403. F(t) is the cumulative exponential distribution func-
tion, we know that F (t = 18 · 4 = 72) = 1− e−β·t = 474Nm ·N f . Therefore, we assume
β=−log (1− 474429·403 )/72, and we denote this value as βB .
3.2 Relationship Break-up Rate perWeek (γ)
It is hard to find an average break-up rate for teenage couples. In some popula-
tions, relationships may be more serious and lasts longer than in other populations.
Therefore, we decide to compare the results between a short-term average break-
up rate, which we set to be 14 couple/week, and a long-term average break-up rate,
which we set to be 126 couple/week.
3.3 Transmission Rate (rsi )
Different transmission rates are proposed by various past studies. After studying 25
men and 25 women at the University of Hawaii, Hernandez et al [15] state that the
female-to-male transmission rate is 4.9/100 person/months, which is substantially
lower than that from male to female (17.4/100 person/months).
In another study involves 179 couples in Canada (female aged 18-24 years, male
aged ≥ 18 ), Burchell et al [8] conclude that there is little difference between the
male-to-female (3.5 per 100 person/months) and female-to-male (4.0 per 100 per-
son/months) transmission rates.
Widdice et al [28] also suggest that female-to-male transmission rates range from
26.8 to 187.5 per 100 person-months and male-to-female transmission ranges from
14.5 to 100 per 100 person-months. However, they also note that the intervals might
be too short.
Referring to the above studies, we assume that HPV transmission rate would
range from 3.5 per 100 person/months to 200 per 100 person/months, i.e. ranges
approximately from 0.01 to 0.5 person per week.
3.4 Probability of Persistent Infection (θ)
We determine θ with Rodriguez’s study on HPV infection [25]. The thirty-month
study is conducted among 599 women in Costa Rica. In figure 4, the curve is al-
most flat after 30 months, so we assume no more people will further recover, and all
the unrecovered people are persistently infected. The clearance percentage after 30
months is 87%, so according to our assumption, the probability of clearance is 0.87.
Then 1− θ = 0.87, and θ = 0.13 is the probability of one infected individual being
persistently infected.
3.5 Rate that a Infected Person Becomes Susceptible (ri s)
We refer to Bogaards’ [16] HPV infection model and assume ri s = 0. Figure 5 de-
scribes the SIRS epidemic model for HPV. In our model, we sum up all the transi-
tional stage, CIN0, CIN1 and CIN2, as the infected stage, I . According to [16], the
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Figure 4: The clearance rate of overall HPV for people under 30 years old. The black
section is the percent of persistently infected people; the dotted section are people
who are currently infected, and the white section is the people who have cleared
HPV [25].
infected people all get immunity after recovery, but this immunity wanes at some
rate rr s , which is going to be described below.
3.6 Rate that a Infected Person Becomes Resistant (ri )
Suppose the number of recovered people stops increasing at the 30th month, and
the slope is almost zero, then Figure 4 [25] resembles a cumulative exponential dis-
tribution: F (x;ri )= 1− e−ri x . Therefore, when x = 1/ri , F (x)= 1−1/e ≈ 0.63. To get
the probability of recovery for one individual, we rescale the y axis from 0 to 0.87 to
0 to 1. From Figure 4 we see F (x) = 0.63 ·0.87 = 0.5481 for x ≈ 6. So ri converted to
weeks should be 124 person per week.
3.7 Rate that a Resistant Person to Susceptible (rr s)
In Figure 7, Bogaards’ [5] measures the rate of waning resistance for 14 types of HPV
based on two studies from Netherlands, one carried out among youths below the
age of 25 years in 2005 [10] and one carried out among adults aged from 18 to 69
years in 2006 [26]. Furthermore, Ortiz et al [17] study the relative prevalence of 15
types of HPV in Spain, and their result is shown in Figure 6.
We calculate the weighted average of rr s by using the posterior density median
for the rate of waning resistance in Figure 7 and the relative prevalence of HPV in
Figure 6, using the numbers in the column under "No.(%) from general population".
Figure 7 does not have HPV type 53, but Figure 6 has, so we deleted the data point
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Figure 5: ri s is indicated by the arrow points from the big box including CIN0, CIN1,
CIN2 to S, as shown in the graph, the value is zero and therefore it is not denoted by
any Greek letter [16].
Figure 6: Relative prevalence of 15 types of HPV in Spain is shown under % from
general population [17]
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Figure 7: The numbers on left column are the medians for transmission probabilities
of 14 types of HPV, and the right column are the medians for wanning resistance for
14 types of HPV [5].
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of type 53 in Figure 7. Therefore, we need to rescale the percentage of "No.(%) from
general population" in Figure 6 by diving each number by 0.782, which is the sum
of all types’ percentage except type 53. Therefore, rr s = 0.17 · 0.041/0.782+ 0.045 ·
0.029/0.782+ 0.014 · 0.068/0.782 = 0.026453 person per year, which is 5.087 · 10−4
person per week. Compared to the values of other parameters, the value of rr s is
negligibly small, so we approximate rr s to be 0 in our model.
4 Model Simulation
To study HPV transmission processes, each time we run 50 simulations with MAT-
LAB, calculate their average and plot the error bar on the graphs. To simplify the
model, we assume the number of females and males are the same in the population-
s, and both equal to 429+4032 = 416. We want to study how these different parameters
will affect the epidemic process, so we also make the following assumptions:
• First of all, we want to simulate HPV transmission with different network pa-
rameters. As discussed in section 3.2, we choose break-up rate to be 14 or
1
26 .
Because relationship formation rate could depend on social factors, such as
age and religion, we would also compare HPV transmission processes with
different relationship formation rate, βB and 3βB .
• According to [2], in some cases, HPV will transmit immediately when a re-
lationship starts, so we choose a large transmission rate 1000 person/week to
represent immediate transmission. Referring to Section 3.3, we also see the H-
PV transmission rate ranges approximately from 0.01 to 0.5 person per week.
To start simple, we set the transmission rates to be 1000 person/week or 0.4
person/week for both genders.
• We choose the initial percentage of infected people in the population, pi , to be
20% and 30%. And θ of the infected population is persistently infected, where
θ = 0.13 as calculated in section 3.4.
In Figure 8 and 9, we plot the sum of I and PI verses time under different sets of
parameters, and we observe that most of the curves are monotonically decreasing.
Only when the relationship formation rate is 3βB and the transmission rate is 1000,
the curves have a bump in our 5-year simulation. In Figure 10 and 11, we observe
that the number of PI all increases. The main interest of our study is to reduce
the number of PI in the population, so we will compare the number of PI under
different sets of parameters.
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Figure 8: The number of I and PI versus time with different network parameters
and initial infected is 30%. In the legend, the first column represents the value of
relationship formation rate; the second column represents break-up rate; third col-
umn represents transmission rate; the rightmost column represents the percentage
of initially infected population.
Figure 9: The number of I and PI versus time with different network parameters
and initial infected is 20%. In the legend, the first column represents the value of
relationship formation rate; the second column represents break-up rate; third col-
umn represents transmission rate; the rightmost column represents the percentage
of initially infected population.
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Figure 10: The number of PI versus time with different network parameters and ini-
tial infected is 20%. In the legend, the first column represents the value of relation-
ship formation rate; the second column represents break-up rate; third column rep-
resents transmission rate; the rightmost column represents the percentage of ini-
tially infected population.
Figure 11: The number of PI versus time with different network parameters and ini-
tial infected is 30%. In the legend, the first column represents the value of relation-
ship formation rate; the second column represents break-up rate; third column rep-
resents transmission rate; the rightmost column represents the percentage of ini-
tially infected population.
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Table 1: PI with different relationship formation rates and break-up rates
(a) when transmission rate is 0.04,
initial infected is 20%
HHHHHβ
γ 1
4
1
26
βB 28.98 37.18
3βB 34.46 80.08
(b) when transmission rate is 0.04,
initial infected is 30%
HHHHHβ
γ 1
4
1
26
βB 45.78 56.22
3βB 53.86 93.62
(c) when transmission rate is 1000, ini-
tial infected is 20%
HHHHHβ
γ 1
4
1
26
βB 59.36 68.54
3βB 107.62 110.46
(d) when transmission rate is 1000, ini-
tial infected is 30%
HHHHHβ
γ 1
4
1
26
βB 77.62 85.3
3βB 113.98 118.32
Table 2: PI with different relationship formation rates and transmission rate
(a) when break-up rate is 14 , initial in-
fected is 20%
HHHHHβ
rsi 0.04 1000
βB 28.98 59.36
3βB 34.46 107.62
(b) when break-up rate is 126 , initial
infected is 20%
HHHHHβ
rsi 0.04 1000
βB 37.18 68.54
3βB 80.08 110.46
(c) when break-up rate is 14 , initial in-
fected is 30%
HHHHHβ
rsi 0.04 1000
βB 45.78 77.62
3βB 53.86 113.98
(d) when break-up rate is 126 , initial
infected is 30%
HHHHHβ
rsi 0.04 1000
βB 56.22 85.3
3βB 93.62 118.32
4.1 PI resulted by different parameters
From all four tables in table 1, we observe that when the relationships form at the
faster rate and break up at a slower rate, more people will get persistently infected.
This is because HPV transmits through relationship networks. When relationship
forms at a faster rate, more couples are formed between infected and susceptible
people. When the break-up rate is slower, the probability that the susceptible person
is infected by his or her infected mate before they break up is also greater.
From table 2, we observe that given other parameters are the same, both larger
relationship formation rate and larger transmission rate will cause more PI in the
end of 5 years. From table 3, we observe that the network with more initially infected
population would result in more PI after 5 years.
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Table 3: PI with different relationship formation rates and initial infected
(a) when break-up rate is 14 , trans-
mission rate is 0.04
HHHHHβ
pi 20% 30%
βB 28.98 45.78
3βB 34.46 53.86
(b) when break-up rate is 126 , trans-
mission rate is 0.04
HHHHHβ
pi 20% 30%
βB 37.18 56.22
3βB 80.08 93.62
(c) when break-up rate is 14 , transmis-
sion rate is 1000
HHHHHβ
pi 20% 30%
βB 59.36 77.62
3βB 107.62 113.98
(d) when break-up rate is 126 , transmis-
sion rate is 1000
HHHHHβ
pi 20% 30%
βB 68.54 85.3
3βB 110.46 118.32
4.2 Introducing Vaccination to One Gender Only
We have shown in section 4.1 how different network parameters will affect the num-
ber of PI, now we will discuss different vaccination strategies. We decide to study
how vaccination will influence populations with different network parameters and
transmission rates. In section 3.2, we notice a wide range of transmission rate from
0.01 to 0.5. Thus, we will study the vaccination strategies under two situations:
• Situation 1: We choose the transmission rate rsi = 0.03, the relationship for-
mation rate to be 5βB , and break-up rate to be
1
52 .
• Situation 2: We choose the transmission rate rsi = 0.4, the relationship forma-
tion rate to be 3βB , and break-up rate to be
1
26 .
In both cases, the initially infected population is 20% of the total population.
Without loss of generality (because we can easily switch the gender in our model),
we introduce vaccination to only girls in the beginning of our research. We define
the percentage of female vaccination to be p f ,v , which means that at time t=0, we
randomly select p f ,v ·N f girls and vaccinate them. We run simulations for p f ,v = i10 ,
when i = 3,4, ...,10. The results are shown in Figure 12-17, and in both situations, I
and PI both further decrease when we vaccinate more females.
When all the females are vaccinated, it seems reasonable to believe that we have
blocked most HPV transmissions and we definitely have protected all female from
high-risk HPV and therefore we will directly prevent cervical cancer, which is 99%
associated to the presence of HPV [12]. However, we could see that the curves of
I +PI in both Figure 12 and Figure 15 start to have a slight increase after reaching
the minimum( in situation 1, it reaches the bottom of 68 people in the 184th week
and rises to 73 in the end; in situation 2, it reaches 70 people in the 138th week and
jumps to 72 in the end. We also notice that for p f ,v = 1.0, the slopes of S is stil-
l negative in Figure 14 and 17. This is because the females in the initially infected
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Figure 12: Situation 1: The number of infected and persistently infected people
changes with time, with the vaccination percentage to be 30%-100% of the total fe-
male population. Transmission rate rsi = 0.03; relationship formation rate is 5βB ;
break-up rate is 152 .
population can still infect the unvaccinated susceptible males. In real life, due to H-
PV’s asymptomatic presentation, an infected individual may get vaccinated without
knowing she is already infected, and she can still transmit HPV to susceptible males.
Full vaccination can be expensive and time-consuming, so we might want to
find a smaller p f ,v that also reduce the number of I and PI drastically. According
to Gertig [13], the HPV Dose-1 vaccination coverage for females in Australia is 81%
for 16-17 years old and 64% for 18-19 years old. Although with larger p f ,v , the sum
of I and PI are always smaller after 312 weeks, we can see that when p f ,v = 0.6 we
already get promising vaccination results, the curve of I +PI no longer have bumps
in both Figure 12 and 15. With p f ,v = 0.6, we also used MATLAB to calculate the
slope for PI during 312th week, and the result is approximately 0.0467 person/week
in situation 1 and 0.0333 person/week in situation 2.
Moreover, if we only vaccinated boys, although mathematically there would not
cause much difference in our model, no females would be protected by the vacci-
nation. The initial infected boys can still transmit HPV, which is a major cause of
cervical cancer, to the susceptible girls. Therefore, in reality, a full vaccination for
female population is preferred over a full vaccination for male population.
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Figure 13: Situation 1: The number of persistently infected people changes with
time, with the vaccination percentage to be 30%-100% of the total female popula-
tion. Transmission rate rsi = 0.03; relationship formation rate is 5βB ; break-up rate
is 152 .
Figure 14: Situation 1: The number of susceptible people changes with time, with
the vaccination percentage to be 30%-100% of the total female population. Trans-
mission rate rsi = 0.03; relationship formation rate is 5βB ; break-up rate is 152 .
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Figure 15: Situation 2: The number of infected and persistently infected people
changes with time, with the vaccination percentage to be 30%-100% of the total fe-
male population. Transmission rate rsi = 0.4; the relationship formation rate is 3βB ;
break-up rate is 126 .
Figure 16: Situation 2: The number of persistently infected people changes with
time, with the vaccination percentage to be 30%-100% of the total female popula-
tion. Transmission rate rsi = 0.4; the relationship formation rate is 3βB ; break-up
rate is 126 .
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Figure 17: Situation 2: The number of susceptible people changes with time, with
the vaccination percentage to be 30%-100% of the total female population. Trans-
mission rate rsi = 0.4; the relationship formation rate is 3βB ; break-up rate is 126 .
4.3 Introducing Vaccination to Girls and Boys under Same Trans-
mission Rates
Even though females are the primary concern regarding the carcinogenic potential
of HPV, infected males spread the virus as well. Here we want to study the vaccina-
tion strategy when there is little difference between the male-to-female (3.5 per 400
person/weeks) and female-to-male (4.0 per 400 person/weeks) transmission rates
[8]. Because of the slight difference of the transmission rates between two genders,
we assume the transmission rates are both 4.0/400 person/ week. We denote the
percentage of male vaccination to be pm,v . Suppose the cost of vaccination is the
same for males and females, with the same percentage of population vaccinated, we
wonder if we can get fewer PI by vaccinating both boys and girls. According to Gertig
[13], the HPV Dose-1 vaccination coverage for females in Australia is 64% for 18-19
years old. Therefore, we chose to vaccinate 60% of the female population, which is
also 30% to total population. In Figures 18-19, we see that the values of I+PI and PI
are almost the same when we only vaccinate one gender, and I+PI and PI are more
when we vaccinate mixtures of females and males.
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Figure 18: Sum of I and PI versus time with vaccination when relationship formation
is 3βB , break-up rate is
1
26 , transmission rate is 4/400, initial infected is 20%, and
total vaccinated percentage is 60%. The first column of the legend is p f ,v , the second
column is pm,v .
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Figure 19: Number of PI versus time with vaccination when relationship formation is
3βB , break-up rate is
1
26 , transmission rate is 4/400,initial infected is 20%, and total
vaccinated percentage is 60%. The first column of the legend is p f ,v , the second
column is pm,v .
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Figure 20: Number of I and PI versus time with vaccination when relationship for-
mation is 3βB , break-up rate is
1
26 , and initial infected is 20%. HPV transmission rate
from male to female was 4.9/400 person/weeks, and from female to male is 17.4/400
person/weeks. The first column of the legend is p f ,v , the second column is pm,v .
4.4 Vaccination Strategy for Different Transmission Rates across
Genders
In Section 4.3, we discuss about the vaccination results for the case when the trans-
mission rates are almost equal across genders. However, according to [15], the H-
PV transmission rate from male to female is 4.9/400 person/weeks, and which from
female to male is 17.4/400 person/weeks. Now we want to study the vaccination
strategy under this circumstance. We vaccinate 30% of the total population (60%
of one gender). In Figure 20 and 21, we see that no combination of p f ,v and pm,v
produces lower I +PI and PI after 312 weeks than the strategy of vaccinating males
only. This is because the transmission rate from female to male is much higher than
the transmission rate from male to female. When we vaccinate more males, we have
protected more of population that has a higher rate of being infected. Therefore,
vaccinating more males gives us better vaccination results.
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Figure 21: Number of PI versus time with vaccination when relationship formation
is 3βB , break-up rate is
1
26 , and initial infected is 20%. HPV transmission rate from
male to female was 4.9/400 person/weeks, and from female to male is 17.4/400 per-
son/weeks. The first column of the legend is p f ,v , the second column is pm,v .
24
5 Conclusion and Recommendations on HPV Vaccina-
tion
We developed a relationship-based dynamic HPV transmission model with param-
eters estimated from both real-life research and past HPV transmission modeling
studies. We first studied how network parameters influenced the number of infect-
ed and persistently infected people in the HPV transmission process. We observed
in our model that HPV transmitted faster in a network with higher relationship for-
mation rate and slower break-up rate. If the population already had a lot of currently
infected people, HPV spread more easily. Since HPV transmission rate estimates in
the literature vary over a wide range [15, 28, 8], we investigated HPV epidemiology
with different transmission rates. Without surprise, higher transmission rates lead
to more infected people.
The impact of vaccination strategies was different in two situations. First, when
the transmission rates across genders were almost equal as suggested in [8], the best
vaccination strategy was to vaccinate one gender. Secondly, when the transmission
rates across genders were different as suggested in [15], where the female-to-male
transmission rate was much higher than the male-to-female transmission rate, vac-
cinating more males yielded a smaller population of infected and persistently in-
fected individuals.
To conclude, we provide the following advice for HPV vaccination based on our
study.
1. HPV vaccination should start early during pre-adolescence stage before the
onset of sexual activity.
As we see in table 3, the number of infected and persistently infected people
increases as the initial infected population increases. Therefore, we need to
start vaccination early before HPV spreads, i.e. vaccination should start in the
pre-adolescent population.
2. HPV vaccination is highly beneficial in promiscuous populations.
In table 1, we see that a faster relationship formation rate and a slower break-
up rate will cause more persistently infected people in the population. With
high relationship formation rate and low break-up rate, there is a high risk of
epidemic spread, but the population can be protected with HPV vaccination.
3. The recommended vaccination percentage is 30% if not higher.
According to our results in Section 4.2, when p f ,v = 0.6, the sum of infected
and persistently infected people never increases, and the curve for persistent-
ly infected people increases with a small slope. Therefore, when we vaccinate
60% of females, we could effectively control the spread of HPV. We assume
the number of females and males are the same in our population. Therefore,
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we recommend that at least 30% of the total population should receive HPV
vaccination.
4. When transmission rates are the same across gender, we verify the results of
past studies: the optimal strategy is to vaccinate only females.
It is shown in Section 4.3 that when transmission rates are the same, vaccinat-
ing only one gender, either male or female, will provide us the optimal result.
The main purpose of HPV vaccination is to reduce the incidence of cervical
cancer which is directly related to HPV infection. If we only vaccinate males,
we are not protecting any females from HPV persistence and cervical cancer.
Therefore, vaccinating females should be prioritized.
5. If the female-to male transmission rate is higher than the male-to-female trans-
mission rate, vaccinating more males will further slow down HPV transmis-
sion than only vaccinating females.
In Section 4.4, when the transmission rates across gender differ in the case
that the female-to male transmission rate is much higher, we observe that
vaccinating males could further decrease the infected population. Therefore,
according to our model, we recommend vaccinate both females and males to
prevent HPV transmission.
In our model, we only consider the case when the population has the same num-
ber of females and males, and for model simplicity, we exclude homosexual rela-
tionships. Moreover, in the process of our research, we have realized the lack of re-
liable experimental estimates for HPV transmission rates. From our simulation, we
have observed different vaccination results caused by different sets of transmission
rates. Therefore, we cannot make a confident recommendation on HPV vaccination
strategy. However, we still get promising results about HPV transmission dynam-
ics with different network parameters and transmission rates, and we also discuss
which vaccination strategies yields optimal results for different sets of transmission
rates.
Appendix
Theorem 1. The sum of I and PI are the same in S-(I,PI)-R and S-I-(R,PI) model
Sketch of proof:
• For S-I-(R,PI) model, starting at time 0, the probability for one susceptible per-
son to become infected at time t is p1 = 1−e−rsi t . Similarly, for S-(I,PI)-R mod-
el, at time 0, the probability for one susceptible person to become either in-
fected or persistently infected is also p ′1 = 1− e−rsi t . The probability for one
person to jump from Stage 1 to Stage 2 is the same.
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Figure 22: S-(I,PI)-R Figure 23: S-I-(R,PI)
• Then we suppose the person is at stage 2. Denote the event that the person is
I or PI at time t as A,
– For S-I-(R,PI) model, the probability of A equals to the sum of the prob-
ability that the infected person has not yet made the jump at time t and
the probability that the person has jumped to PI at time t, which is p2 =
e−ri t + (1−e−ri t ) θri(1−θ)ri+θri = θ−θe
−ri t +e−ri t .
– For S-(I,PI)-R model, the probability of P equals to the sum of the proba-
bility that the person is persistently infected and the probability that the
person is infected but has not become resistent, which is p ′2 = θ+ (1−
θ)e−ri t = θ−θe−ri t +e−ri t .
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